Immunotherapy, also called biologic therapy, is a type of cancer treatment that boosts the body's natural defenses to fight cancer.
This report aims to provide a comprehensive presentation of the global market for Cancer Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Immunotherapy. This report contains market size and forecasts of Cancer Immunotherapy in global, including the following market information:
Global Cancer Immunotherapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Cancer Immunotherapy market was valued at US$ 78150 million in 2022 and is projected to reach US$ 131790 million by 2029, at a CAGR of 7.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Monoclonal Antibodies Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cancer Immunotherapy include Amgen, AstraZeneca, Roche, Bayer, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis and Pfizer, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer Immunotherapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Immunotherapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Cancer Immunotherapy Market Segment Percentages, by Type, 2022 (%)
Monoclonal Antibodies
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
Global Cancer Immunotherapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Cancer Immunotherapy Market Segment Percentages, by Application, 2022 (%)
Lung Cancer
Breast Cancer
Colorectal Cancer
Melanoma
Prostate Cancer
Others
Global Cancer Immunotherapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Cancer Immunotherapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Immunotherapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cancer Immunotherapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
AstraZeneca
Roche
Bayer
Bristol-Myers Squibb
Eli Lilly
Merck
Novartis
Pfizer
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Immunotherapy, market overview.
Chapter 2: Global Cancer Immunotherapy market size in revenue.
Chapter 3: Detailed analysis of Cancer Immunotherapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Immunotherapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Immunotherapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Immunotherapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Immunotherapy Overall Market Size
2.1 Global Cancer Immunotherapy Market Size: 2022 VS 2029
2.2 Global Cancer Immunotherapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Immunotherapy Players in Global Market
3.2 Top Global Cancer Immunotherapy Companies Ranked by Revenue
3.3 Global Cancer Immunotherapy Revenue by Companies
3.4 Top 3 and Top 5 Cancer Immunotherapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cancer Immunotherapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Immunotherapy Players in Global Market
3.6.1 List of Global Tier 1 Cancer Immunotherapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Immunotherapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Immunotherapy Market Size Markets, 2022 & 2029
4.1.2 Monoclonal Antibodies
4.1.3 Immune Checkpoint Inhibitors
4.1.4 Immune System Modulators
4.1.5 Cancer Vaccines
4.2 By Type - Global Cancer Immunotherapy Revenue & Forecasts
4.2.1 By Type - Global Cancer Immunotherapy Revenue, 2018-2023
4.2.2 By Type - Global Cancer Immunotherapy Revenue, 2024-2029
4.2.3 By Type - Global Cancer Immunotherapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Immunotherapy Market Size, 2022 & 2029
5.1.2 Lung Cancer
5.1.3 Breast Cancer
5.1.4 Colorectal Cancer
5.1.5 Melanoma
5.1.6 Prostate Cancer
5.1.7 Others
5.2 By Application - Global Cancer Immunotherapy Revenue & Forecasts
5.2.1 By Application - Global Cancer Immunotherapy Revenue, 2018-2023
5.2.2 By Application - Global Cancer Immunotherapy Revenue, 2024-2029
5.2.3 By Application - Global Cancer Immunotherapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Cancer Immunotherapy Market Size, 2022 & 2029
6.2 By Region - Global Cancer Immunotherapy Revenue & Forecasts
6.2.1 By Region - Global Cancer Immunotherapy Revenue, 2018-2023
6.2.2 By Region - Global Cancer Immunotherapy Revenue, 2024-2029
6.2.3 By Region - Global Cancer Immunotherapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Cancer Immunotherapy Revenue, 2018-2029
6.3.2 US Cancer Immunotherapy Market Size, 2018-2029
6.3.3 Canada Cancer Immunotherapy Market Size, 2018-2029
6.3.4 Mexico Cancer Immunotherapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Cancer Immunotherapy Revenue, 2018-2029
6.4.2 Germany Cancer Immunotherapy Market Size, 2018-2029
6.4.3 France Cancer Immunotherapy Market Size, 2018-2029
6.4.4 U.K. Cancer Immunotherapy Market Size, 2018-2029
6.4.5 Italy Cancer Immunotherapy Market Size, 2018-2029
6.4.6 Russia Cancer Immunotherapy Market Size, 2018-2029
6.4.7 Nordic Countries Cancer Immunotherapy Market Size, 2018-2029
6.4.8 Benelux Cancer Immunotherapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Cancer Immunotherapy Revenue, 2018-2029
6.5.2 China Cancer Immunotherapy Market Size, 2018-2029
6.5.3 Japan Cancer Immunotherapy Market Size, 2018-2029
6.5.4 South Korea Cancer Immunotherapy Market Size, 2018-2029
6.5.5 Southeast Asia Cancer Immunotherapy Market Size, 2018-2029
6.5.6 India Cancer Immunotherapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Cancer Immunotherapy Revenue, 2018-2029
6.6.2 Brazil Cancer Immunotherapy Market Size, 2018-2029
6.6.3 Argentina Cancer Immunotherapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Immunotherapy Revenue, 2018-2029
6.7.2 Turkey Cancer Immunotherapy Market Size, 2018-2029
6.7.3 Israel Cancer Immunotherapy Market Size, 2018-2029
6.7.4 Saudi Arabia Cancer Immunotherapy Market Size, 2018-2029
6.7.5 UAE Cancer Immunotherapy Market Size, 2018-2029
7 Cancer Immunotherapy Companies Profiles
7.1 Amgen
7.1.1 Amgen Company Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Cancer Immunotherapy Major Product Offerings
7.1.4 Amgen Cancer Immunotherapy Revenue in Global Market (2018-2023)
7.1.5 Amgen Key News & Latest Developments
7.2 AstraZeneca
7.2.1 AstraZeneca Company Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Cancer Immunotherapy Major Product Offerings
7.2.4 AstraZeneca Cancer Immunotherapy Revenue in Global Market (2018-2023)
7.2.5 AstraZeneca Key News & Latest Developments
7.3 Roche
7.3.1 Roche Company Summary
7.3.2 Roche Business Overview
7.3.3 Roche Cancer Immunotherapy Major Product Offerings
7.3.4 Roche Cancer Immunotherapy Revenue in Global Market (2018-2023)
7.3.5 Roche Key News & Latest Developments
7.4 Bayer
7.4.1 Bayer Company Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Cancer Immunotherapy Major Product Offerings
7.4.4 Bayer Cancer Immunotherapy Revenue in Global Market (2018-2023)
7.4.5 Bayer Key News & Latest Developments
7.5 Bristol-Myers Squibb
7.5.1 Bristol-Myers Squibb Company Summary
7.5.2 Bristol-Myers Squibb Business Overview
7.5.3 Bristol-Myers Squibb Cancer Immunotherapy Major Product Offerings
7.5.4 Bristol-Myers Squibb Cancer Immunotherapy Revenue in Global Market (2018-2023)
7.5.5 Bristol-Myers Squibb Key News & Latest Developments
7.6 Eli Lilly
7.6.1 Eli Lilly Company Summary
7.6.2 Eli Lilly Business Overview
7.6.3 Eli Lilly Cancer Immunotherapy Major Product Offerings
7.6.4 Eli Lilly Cancer Immunotherapy Revenue in Global Market (2018-2023)
7.6.5 Eli Lilly Key News & Latest Developments
7.7 Merck
7.7.1 Merck Company Summary
7.7.2 Merck Business Overview
7.7.3 Merck Cancer Immunotherapy Major Product Offerings
7.7.4 Merck Cancer Immunotherapy Revenue in Global Market (2018-2023)
7.7.5 Merck Key News & Latest Developments
7.8 Novartis
7.8.1 Novartis Company Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Cancer Immunotherapy Major Product Offerings
7.8.4 Novartis Cancer Immunotherapy Revenue in Global Market (2018-2023)
7.8.5 Novartis Key News & Latest Developments
7.9 Pfizer
7.9.1 Pfizer Company Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Cancer Immunotherapy Major Product Offerings
7.9.4 Pfizer Cancer Immunotherapy Revenue in Global Market (2018-2023)
7.9.5 Pfizer Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Immunotherapy Market Opportunities & Trends in Global Market
Table 2. Cancer Immunotherapy Market Drivers in Global Market
Table 3. Cancer Immunotherapy Market Restraints in Global Market
Table 4. Key Players of Cancer Immunotherapy in Global Market
Table 5. Top Cancer Immunotherapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cancer Immunotherapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cancer Immunotherapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cancer Immunotherapy Product Type
Table 9. List of Global Tier 1 Cancer Immunotherapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Immunotherapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cancer Immunotherapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Cancer Immunotherapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cancer Immunotherapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Cancer Immunotherapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Cancer Immunotherapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cancer Immunotherapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Cancer Immunotherapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Cancer Immunotherapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cancer Immunotherapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Cancer Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cancer Immunotherapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Cancer Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cancer Immunotherapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Cancer Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cancer Immunotherapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Cancer Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cancer Immunotherapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Cancer Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cancer Immunotherapy Revenue, (US$, Mn), 2024-2029
Table 30. Amgen Company Summary
Table 31. Amgen Cancer Immunotherapy Product Offerings
Table 32. Amgen Cancer Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 33. Amgen Key News & Latest Developments
Table 34. AstraZeneca Company Summary
Table 35. AstraZeneca Cancer Immunotherapy Product Offerings
Table 36. AstraZeneca Cancer Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 37. AstraZeneca Key News & Latest Developments
Table 38. Roche Company Summary
Table 39. Roche Cancer Immunotherapy Product Offerings
Table 40. Roche Cancer Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 41. Roche Key News & Latest Developments
Table 42. Bayer Company Summary
Table 43. Bayer Cancer Immunotherapy Product Offerings
Table 44. Bayer Cancer Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 45. Bayer Key News & Latest Developments
Table 46. Bristol-Myers Squibb Company Summary
Table 47. Bristol-Myers Squibb Cancer Immunotherapy Product Offerings
Table 48. Bristol-Myers Squibb Cancer Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 49. Bristol-Myers Squibb Key News & Latest Developments
Table 50. Eli Lilly Company Summary
Table 51. Eli Lilly Cancer Immunotherapy Product Offerings
Table 52. Eli Lilly Cancer Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 53. Eli Lilly Key News & Latest Developments
Table 54. Merck Company Summary
Table 55. Merck Cancer Immunotherapy Product Offerings
Table 56. Merck Cancer Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 57. Merck Key News & Latest Developments
Table 58. Novartis Company Summary
Table 59. Novartis Cancer Immunotherapy Product Offerings
Table 60. Novartis Cancer Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 61. Novartis Key News & Latest Developments
Table 62. Pfizer Company Summary
Table 63. Pfizer Cancer Immunotherapy Product Offerings
Table 64. Pfizer Cancer Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 65. Pfizer Key News & Latest Developments
List of Figures
Figure 1. Cancer Immunotherapy Segment by Type in 2022
Figure 2. Cancer Immunotherapy Segment by Application in 2022
Figure 3. Global Cancer Immunotherapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cancer Immunotherapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Cancer Immunotherapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Immunotherapy Revenue in 2022
Figure 8. By Type - Global Cancer Immunotherapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Cancer Immunotherapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Cancer Immunotherapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Cancer Immunotherapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Cancer Immunotherapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Cancer Immunotherapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Cancer Immunotherapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Cancer Immunotherapy Revenue Market Share, 2018-2029
Figure 16. US Cancer Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Cancer Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Cancer Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Cancer Immunotherapy Revenue Market Share, 2018-2029
Figure 20. Germany Cancer Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Cancer Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Cancer Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Cancer Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Cancer Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Cancer Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Cancer Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Cancer Immunotherapy Revenue Market Share, 2018-2029
Figure 28. China Cancer Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Cancer Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Cancer Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Cancer Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Cancer Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Cancer Immunotherapy Revenue Market Share, 2018-2029
Figure 34. Brazil Cancer Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Cancer Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Cancer Immunotherapy Revenue Market Share, 2018-2029
Figure 37. Turkey Cancer Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Cancer Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Cancer Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Cancer Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 41. Amgen Cancer Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. AstraZeneca Cancer Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Roche Cancer Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Bayer Cancer Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bristol-Myers Squibb Cancer Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Eli Lilly Cancer Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Merck Cancer Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Novartis Cancer Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Pfizer Cancer Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
